Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?

A new treatment option for pancreatic cancer patients, using electric field-generating devices by Novocure and Zai Lab, shows promising results in increasing survival rates. With FDA approvals for lung cancer treatment, Novocure's stock is on the rise, hinting at a profitable future.